Bill Few Associates’s Bristol-Myers Squibb BMY Stock Holding History

Bill Few Associates’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$684K	Buy	11,876 +2,245	+23%	+$129K	0.15%	110
2026 Q1	$584K	Sell	9,631 -59	-0.6%	-$3.44K	0.14%	111
2025 Q4	$523K	Buy	9,690 +404	+4%	+$19.4K	0.13%	113
2025 Q3	$419K	Sell	9,286 -1,309	-12%	-$61.1K	0.11%	126
2025 Q2	$490K	Buy	10,595 +633	+6%	+$31.1K	0.14%	111
2025 Q1	$608K	Sell	9,962 -28	-0.3%	-$1.63K	0.22%	85
2024 Q4	$565K	Buy	9,990 +125	+1%	+$6.98K	0.2%	86
2024 Q3	$510K	Buy	9,865 +160	+2%	+$7.51K	0.18%	100
2024 Q2	$403K	Buy	9,705 +101	+1%	+$4.52K	0.15%	111
2024 Q1	$521K	Buy	9,604 +450	+5%	+$22.9K	0.21%	84
2023 Q4	$470K	Buy	9,154 +725	+9%	+$38.1K	0.21%	88
2023 Q3	$489K	Sell	8,429 -325	-4%	-$19.9K	0.26%	74
2023 Q2	$560K	Sell	8,754 -75	-0.8%	-$5.03K	0.29%	71
2023 Q1	$612K	Buy	8,829 +800	+10%	+$56.4K	0.34%	62
2022 Q4	$578K	Hold	8,029	–	–	0.34%	63
2022 Q3	$570K	Sell	8,029 -200	-2%	-$14.5K	0.39%	57
2022 Q2	$634K	Hold	8,229	–	–	0.41%	53
2022 Q1	$601K	Buy	8,229 +324	+4%	+$21.8K	0.33%	58
2021 Q4	$493K	Buy	+7,905	New	+$464K	0.26%	69

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Bill Few Associates's BMY Position: Q2 2026 in Review

Bill Few Associates increased its Bristol-Myers Squibb (BMY) stake by 23% in Q2 2026, buying an estimated $129K and bringing the position to 11,876 shares worth $684K. The position accounts for 0.15% of the portfolio, ranked #110.

Bill Few Associates first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. 896 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Bill Few Associates held 11,876 shares of Bristol-Myers Squibb worth $684K as of Q2 2026.
Bill Few Associates bought 2,245 Bristol-Myers Squibb shares in Q2 2026, an estimated $129K.
Bristol-Myers Squibb made up 0.15% of Bill Few Associates's portfolio in Q2 2026, its #110 holding.
Bill Few Associates first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
896 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bill Few Associates's 13F filing for Q2 2026, filed 7 Jul 2026.